Vitruvian Partners LLP 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
Vitruvian Partners LLP disclosed 7 US equity positions worth $144.2m in its Q3 2025 13F filing. The largest position was HNGE at 42.5% of the reported book, followed by MQ and CARG. Against the Q2 2025 filing, it opened 0 new positions, added to 1 and reduced 2 among the top 7 holdings.
What did Vitruvian Partners LLP own in Q3 2025? Top 7 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | HNGE HINGE HEALTH INC | Healthcare | 42.5% | $61.4m | 1,250,000 | 0% | held |
| 2 | MQ MARQETA | Technology | 25.1% | $36.2m | 6,853,183 | 0% | held |
| 3 | CARG CARGURUS INC | Communication Services | 12.2% | $17.6m | 472,959 | -50% | reduced |
| 4 | XMTR XOMETRY INC | 8.9% | $12.8m | 235,660 | -14% | reduced | |
| 5 | MXCT MAXCYTE | 5.5% | $8.0m | 5,043,356 | 0% | held | |
| 6 | GLBE GLOBAL-E | Consumer Cyclical | 4.3% | $6.2m | 172,442 | 23% | added |
| 7 | RXST RXSIGHT | Healthcare | 1.4% | $2.1m | 230,743 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.